Estimaciones de analistas de Wall Street para Bolt Biotherapeutics, Inc. (BOLT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 3 |
| Mantener | 5 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 8 |
| Calificación media (1-5) | 0.38 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-3.89 | ||
| 2026-08-11 | $-4.57 | $-3.39 | -34.8% |
| 2026-05-12 | $-4.31 | $-2.85 | -51.2% |
| 2026-03-12 | $-3.84 | $-4.30 | +10.7% |
| 2025-11-12 | $-3.72 | $-5.07 | +26.6% |
| 2025-08-14 | $-4.46 | $-6.40 | +30.3% |
| 2025-05-12 | $-5.80 | $-6.80 | +14.7% |
| 2025-03-24 | $-7.60 | $-7.60 | +0.0% |
Ratios de valoración
| Precio / Valor contable | 0.49 |
| EV / EBITDA | -0.67 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | $215000 | $231000 | $1.3M | $5.7M | $7.9M | $7.7M | $7.7M |
| Coste de Ventas | $302000 | 0 | $40.4M | $75.7M | $73.1M | $61.5M | 0 | $1.5M |
| Beneficio Bruto | -$302000 | $215000 | -$40.1M | -$74.4M | -$67.4M | -$53.7M | $7.7M | $6.2M |
| I+D | $9.4M | $26.0M | $40.4M | $75.7M | $73.1M | $61.5M | $57.5M | $28.5M |
| Generales y Administrativos | $2.2M | $5.2M | $9.1M | $18.4M | $22.9M | $22.5M | $18.5M | $13.8M |
| Gastos Operativos | $11.6M | $31.2M | $9.1M | $18.4M | $22.9M | $22.5M | $80.7M | $40.8M |
| Beneficio Operativo | -$11.6M | -$31.0M | -$49.2M | -$92.8M | -$90.3M | -$76.2M | -$73.0M | -$34.6M |
| EBITDA | -$11.3M | -$30.6M | -$48.6M | -$97.4M | -$86.4M | -$67.3M | -$66.5M | -$31.9M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$11.6M | -$30.5M | -$60.7M | -$98.6M | -$88.1M | -$69.2M | -$63.1M | -$33.4M |
| Impuestos | $40000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$11.6M | -$30.5M | -$60.7M | -$98.6M | -$88.1M | -$69.2M | -$63.1M | -$33.4M |
| BPA | $-5.96 | $-3.75 | $-1.99 | $-2.79 | $-2.30 | $-1.83 | $-1.65 | $-17.85 |
| BPA Diluido | $-5.96 | $-3.75 | $-1.99 | $-2.79 | $-2.30 | $-1.83 | $-1.65 | $-17.85 |
| Acciones en Circulación (Diluidas) | $97186 | $400497 | $1.8M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M |
Precio
| Precio | $3.63 |
| Capitalización | $7M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AEON · CING · CLRB · EVGN · IMNN · INAB · LYRA
Explorar sector: Healthcare · Biotechnology
Más secciones de BOLT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones